Case study

SENORES

SENORES PHARMACEUTICALS L

Mixed signals1y model +57.7%

Each stock's 10,000-path forecast, rendered as light.

0Score

SENORES PHARMACEUTICALS L (SENORES) Stock Analysis & Case Study

Is SENORES a good buy? The data-driven verdict.

on the numbers it mixed signals, a Downstox Snapshot Score of 53/100.

On the numbers, SENORES PHARMACEUTICALS L (SENORES) mixed signals, a Downstox Snapshot Score of 53/100, weighing a 83% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 20272031.

Last updated . Data snapshot for research, not investment advice.

SENORES share price target 2027, 2028, 2029, 2030, 2031, a probability view

Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 1.5y of SENORES history (58%/yr drift, 48%/yr volatility).

YearLow (P10)Median target (P50)High (P90)Upside vs today
SENORES 2027₹1,090₹2,042₹3,845+58%
SENORES 2028₹1,338₹3,251₹7,903+151%
SENORES 2029₹1,749₹5,169₹15,052+299%
SENORES 2030₹2,343₹8,073₹28,276+524%
SENORES 2031₹3,180₹12,882₹51,802+895%

Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.

What is the probability SENORES goes up, or doubles?

83%
Higher in 1 year
Modelled chance the price is above today in 12 months
98%
Higher in 5 years
Modelled chance the price is above today in 5 years
93%
Doubles in 5 years
Modelled chance of reaching ₹2,589 within 5 years

The bull case for SENORES

  • A 10,000-path probability model puts a 83% chance the price is higher in a year, with a median target of ₹2,042 (+58%).
  • Upside scenario: the model's optimistic (P90) 3-year path reaches ₹15,052.

The bear case & risks

  • High historical volatility (48%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
  • Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹1,749.

SENORES volatility & expected range, how bumpy is the ride?

Over the last 1.5 years SENORES compounded at 58%/year with annualized volatility of 48%. That volatility implies a 1-year 80% range of ₹1,090₹3,845, the honest backbone behind any single price target.

SENORES price forecast, the full 60-month probability fan

Spot Price · Today
₹0
Based on 1.5 years of daily NSE data ·0.0% annualised volatility
5-yr median forecast
₹0
P(price ↑ in 5y)
0%
1-Year Forecast
2027
₹0
Median (P50)
57.7%
80% range₹1,090–₹3,845
P(price ↑)83%
P(price 2×)31%
3-Year Forecast
2029
₹0
Median (P50)
299.3%
80% range₹1,749–₹15,052
P(price ↑)95%
P(price 2×)79%
5-Year Forecast
2031
₹0
Median (P50)
895.3%
80% range₹3,180–₹51,802
P(price ↑)98%
P(price 2×)93%

SENORES price probability fan

Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.

Probability Fan
SENORES simulated paths · 60 months · 10,000 trials
P10–P90 (80%)P25–P75 (50%)Median (P50)

Probability of key outcomes

What are the odds SENORES hits common targets within the simulated horizon?

0%
P(↑ 1Y)
Above today's price in 1 year
0%
P(↑ 5Y)
Above today's price in 5 years
0%
P(2×)
Doubles within 5 years
0%
P(↓)
Falls below today in 5 years

Full multi-horizon detail on the SENORES price target & forecast page.

SENORES MTF margin & leverage, Upstox, Zerodha, Groww, Dhan

Margin Trading Facility lets you buy SENORES with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):

BrokerMargin requiredApprox. leverage
UpstoxCHEAPEST35.1%2.8×
ZerodhaCHEAPEST35.1%2.8×
DhanCHEAPEST35.1%2.8×

Compare every broker on the SENORES MTF page.

SENORES vs peers,sector comparison

StockP/EDiv yieldMarket cap
SENORES (this stock)
RELIANCE23.1×0.45%₹17.95L Cr
TCS14.7×3.01%₹7.69L Cr
HDFCBANK15.9×1.65%₹12.11L Cr
INFY14.4×4.51%₹4.32L Cr
ICICIBANK17.9×0.81%₹9.70L Cr
SBIN11.5×1.67%₹9.61L Cr

About SENORES PHARMACEUTICALS L: sector, index & market-cap context

SENORES PHARMACEUTICALS L (SENORES) is an NSE-listed company.

How the SENORES Snapshot Score & forecast are built

The Downstox Snapshot Score is a transparent, rules-based read of SENORES PHARMACEUTICALS L's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.

This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.

SENORES analysis, FAQs

Is SENORES PHARMACEUTICALS L (SENORES) a good buy?

On the numbers, SENORES PHARMACEUTICALS L (SENORES) mixed signals, a Downstox Snapshot Score of 53/100, weighing a 83% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.

Is SENORES overvalued or undervalued?

Valuation ratios for SENORES are tracked live on Downstox.

What is the SENORES share price target for 2031?

SENORES's probability-weighted 2031 median target is ₹12,882, with an 80% range of ₹3,180₹51,802 (10,000-path Monte-Carlo).

What is the probability SENORES doubles in 5 years?

The modelled probability of SENORES reaching ₹2,589 (2×) within 5 years is 93%.

What is the bull case for SENORES?

A 10,000-path probability model puts a 83% chance the price is higher in a year, with a median target of ₹2,042 (+58%).

What are the risks in SENORES?

High historical volatility (48%/yr) means a wide, bumpy range of outcomes, size positions accordingly.

More on SENORES